Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial [Original Articles]

Conclusions— Thromboembolic events on dabigatran led to early termination of a randomized controlled trial of dabigatran versus phenprocoumon in left ventricular assist device patients. Clinical Trial Registration— https://www.clinicaltrials.gov. Unique identifier: NCT02872649.

http://circheartfailure.ahajournals.org/cgi/content/short/10/5/e003709?rss=1

Source: Circulation: Heart Failure - May 12, 2017 Category: Cardiology Authors: Andreas, M., Moayedifar, R., Wieselthaler, G., Wolzt, M., Riebandt, J., Haberl, T., Angleitner, P., Schloglhofer, T., Wiedemann, D., Schima, H., Laufer, G., Zimpfer, D. Tags: Cardiomyopathy, Heart Failure, Anticoagulants, Cardiovascular Surgery Original Articles Source Type: research